Clinical Trials Browser

Phase EARLY_PHASE1 × OTHER × Interleukin 1 Receptor Antagonist Protein × Clear all

NCT02550327 2021-06-22

Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer

Phase EARLY_PHASE1 Completed

Gastrointestinal

Pancreatic Adenocarcinoma